<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E29E26FC-3B0D-4349-8758-A476A67D7F47"><gtr:id>E29E26FC-3B0D-4349-8758-A476A67D7F47</gtr:id><gtr:name>The Leducq Foundation (Fondation Leducq)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Cardiovascular</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E29E26FC-3B0D-4349-8758-A476A67D7F47"><gtr:id>E29E26FC-3B0D-4349-8758-A476A67D7F47</gtr:id><gtr:name>The Leducq Foundation (Fondation Leducq)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F93131C2-9CE4-4B62-AB5B-77A4C668934F"><gtr:id>F93131C2-9CE4-4B62-AB5B-77A4C668934F</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Eaton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700320"><gtr:id>15A51FC3-C989-4A28-BA85-D8FF3939BA6A</gtr:id><gtr:title>An investigation of a novel redox-mediated regulation of protein kinase G in the heart</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700320</gtr:grantReference><gtr:abstractText>Free radicals and oxidising chemicals are produced in cells and tissues. Historically these have been primarily associated with disease or dysfunction. However, over the past decade there has been a growing realisation that these species are not always harmful, and in fact they can play important regulatory roles. We have found in preliminary studies that a protein (known as protein kinase G, specifically the 1 alpha isoform), which is very important for how the heart is regulated is chemically modified by oxidants and this directly activates it. Here we outline studies that will help fully define the importance of this modification and activation of protein kinase G, both in health and in disease. We will utilise many experimental approaches in this work, including generation of a genetically modified mouse that has been altered so that it cannot be oxidised and directly activated by oxidants. The availability of such mice would be an invaluable resource that will allow us to study fully the importance of oxidant-induced protein kinase A activation in cells, tissues, organs and the animal as a whole.</gtr:abstractText><gtr:technicalSummary>We have recently found that protein kinase G (PKG), specifically the 1 alpha isoform, is subject to reversible cysteine-targeted oxidation, a modification that regulates the activity of this kinase. This oxidative cysteine modification involves a disulfide bond forming between the two homodimer chains of this kinase. In this application, which is aimed at further understanding the significance of this oxidative modification of PKG, we outline two primary lines of investigation. (1) A program of experiments that will further characterise the fundamental nature of this mode of kinase activation. (2) We also propose the generation of knock-in mice where wild-type PKG 1 alpha is replaced with mutants lacking the cysteines required for kinase disulfide bond formation. The generation of these mice will be an invaluable resource in which we can carry out the key experiments further investigating the activation of PKG by oxidants, and also the role of this novel mode of kinase activation in pathologies that involve chronic oxidant stress.</gtr:technicalSummary><gtr:fund><gtr:end>2012-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>664855</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Leducq Foundation (Fondation Leducq)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Redox and Nitrosative Regulation of Cardiac Remodeling: Novel Therapeutic Approaches for Heart Failure</gtr:department><gtr:description>Leducq Foundation</gtr:description><gtr:id>6AB9BDCA-86AA-4C61-B3D8-369362BF8AF2</gtr:id><gtr:impact>This funding was key to several publications and has helped generate pilot data for grant applications.</gtr:impact><gtr:partnerContribution>Funding was provided and they also facilitate regular meetings of the group.</gtr:partnerContribution><gtr:piContribution>We have helped form a team of European / North American resaercghers studying herat failure, and the role of oxidative stress.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>lay review for BIOLOGIST MAGAZINE</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>650108F7-0A25-44E9-A912-F452DB122564</gtr:id><gtr:impact>Burgoyne JR and Eaton P (2009). Beating the silent killer: a new way to relax. Biologist 56 (1), 40-44.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>381870</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Does redox state of PKG1alpha control hypoxic vasoconstriction and remodelling in the pulmonary vasculature?</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>4B8EF9A4-610C-42AD-B4A8-EB820950C86C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fondation Leducq, Transatlantic Network of Excellence</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Transatlantic Networks of Excellence in Cardiovascular Research Program</gtr:fundingOrg><gtr:id>E22AA5E8-02B7-4130-9478-0083DA35495C</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>886910</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Protein kinase G oxidation in the pathogenesis of cardiovascular disease</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/12/12/29872</gtr:fundingRef><gtr:id>8D9C7B59-1249-4FC0-96F8-03D6457DAA1B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>502927</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Disulfide activated protein kinase G Ialpha as a new therapeutic target in sepsis</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>F06F05E8-FDA5-4E2C-8EFF-ADF91AB91A12</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>372459</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Oxidant-induced activation of protein kinase A</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C7BAE46D-422A-4C9A-86DB-5AC8A957290F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>381870</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Does redox state of PKG1alpha control hypoxic vasoconstriction and remodelling in the pulmonary vasculature?</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>E9A4988D-CBAA-4420-A84A-CAA7D34EC1DC</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>193642</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Novel approaches to understanding oxidant sensing and signalling in the cardiovascular system</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>E63AAE89-208C-4FBA-AE17-8A9D41861522</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>159098</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>6C863658-93C4-45ED-B8BA-9275E169C6EC</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>502927</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>Disulfide activated protein kinase G Ialpha as a new therapeutic target in sepsis</gtr:fundingRef><gtr:id>930471C0-2187-4204-A586-62C8128276D7</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2255659</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Advanced - CARDIOREDOX</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>339095</gtr:fundingRef><gtr:id>769F00EF-9E65-490F-B2C4-469FE000010D</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>380000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fondation Leducq, Transatlantic Network of Excellence</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Transatlantic Networks of Excellence in Cardiovascular Research Program</gtr:fundingOrg><gtr:id>AA76C7C3-0D73-411E-B57F-0EDD510043BC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>a &amp;quot;redox dead&amp;quot; PKG1alpha Cys42Ser knock-in mouse line has been created. It is being studied currently.</gtr:description><gtr:id>BC4EC6A3-B556-4625-B682-F31283C4E197</gtr:id><gtr:impact>Thuis mouse odel has helped us get further funding. It will be supplied to other cardiovascular researchers in the coming year.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PKG1alpha Cys42Ser knock-in mouse line</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Novel mouse line that contains PKA protein that is 'redox-dead'</gtr:description><gtr:id>52CD5EDA-48DA-444E-A6CB-F2D3D82D8A48</gtr:id><gtr:impact>work in progress</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cys17Ser RI PKA redox-dead mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic mouse Cys42Ser &amp;quot;redox-dead&amp;quot; mutant</gtr:description><gtr:id>DD270739-9DB4-4BB5-A0F1-7A3FE229D2BD</gtr:id><gtr:impact>It is a solid platform on which to base upcoming studies assessing the role of PKG oxidation in health and disease</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cys42Ser &quot;redox-dead&quot; mutant</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0763BCF0-E232-48FF-B772-71F2475DB0A9"><gtr:id>0763BCF0-E232-48FF-B772-71F2475DB0A9</gtr:id><gtr:title>Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cbed28a17d7662fcab9fa50de717115c"><gtr:id>cbed28a17d7662fcab9fa50de717115c</gtr:id><gtr:otherNames>Charles RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53BCC910-40D9-4DBE-A50A-9758BADC79F2"><gtr:id>53BCC910-40D9-4DBE-A50A-9758BADC79F2</gtr:id><gtr:title>Contemporary techniques for detecting and identifying proteins susceptible to reversible thiol oxidation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4927DE99-E12E-4C57-AACD-8C65FA6E4C46"><gtr:id>4927DE99-E12E-4C57-AACD-8C65FA6E4C46</gtr:id><gtr:title>Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Heart and circulatory physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54f6b78b2da73cabaa74461d3377ee84"><gtr:id>54f6b78b2da73cabaa74461d3377ee84</gtr:id><gtr:otherNames>Bell JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0363-6135</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3003D29D-593E-445D-903F-869C0497FE1C"><gtr:id>3003D29D-593E-445D-903F-869C0497FE1C</gtr:id><gtr:title>Analysis of Mitochondrial Proteins in the Surviving Myocardium after Ischemia Identifies Mitochondrial Pyruvate Carrier Expression as Possible Mediator of Tissue Viability.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7fc6c914b558105b035d74da8d9f4601"><gtr:id>7fc6c914b558105b035d74da8d9f4601</gtr:id><gtr:otherNames>Fern?ndez-Caggiano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/72BD904F-7FE8-48B0-8294-50C7C44BAD3D"><gtr:id>72BD904F-7FE8-48B0-8294-50C7C44BAD3D</gtr:id><gtr:title>Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dba285335691f3955553a3c3cb4a916b"><gtr:id>dba285335691f3955553a3c3cb4a916b</gtr:id><gtr:otherNames>Hohl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF4E2E47-22BC-4496-AC8B-EA36325E74C9"><gtr:id>DF4E2E47-22BC-4496-AC8B-EA36325E74C9</gtr:id><gtr:title>Biochemical methods for monitoring protein thiol redox states in biological systems.</gtr:title><gtr:parentPublicationTitle>Redox biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2226d4078053c470b78cb99103ef2fa1"><gtr:id>2226d4078053c470b78cb99103ef2fa1</gtr:id><gtr:otherNames>Rudyk O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/286687D8-4B0E-4FA5-973B-2130508B0C17"><gtr:id>286687D8-4B0E-4FA5-973B-2130508B0C17</gtr:id><gtr:title>Nitrosative protein oxidation is modulated during early endotoxemia.</gtr:title><gtr:parentPublicationTitle>Nitric oxide : biology and chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1089-8603</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6D95C589-AA83-4576-93E8-D953EFEBCDD1"><gtr:id>6D95C589-AA83-4576-93E8-D953EFEBCDD1</gtr:id><gtr:title>Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70A47D8D-D480-4044-AF37-8D9ED45E406E"><gtr:id>70A47D8D-D480-4044-AF37-8D9ED45E406E</gtr:id><gtr:title>How widespread is stable protein S-nitrosylation as an end-effector of protein regulation?</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/34c9531e1c147448d2c0880c8faaaa47"><gtr:id>34c9531e1c147448d2c0880c8faaaa47</gtr:id><gtr:otherNames>Wolhuter K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3D70850-D881-4070-91D7-EFCEBE91AC9B"><gtr:id>F3D70850-D881-4070-91D7-EFCEBE91AC9B</gtr:id><gtr:title>A rapid approach for the detection, quantification, and discovery of novel sulfenic acid or S-nitrosothiol modified proteins using a biotin-switch method.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2535884-D759-447F-8509-72C12BC7F95E"><gtr:id>B2535884-D759-447F-8509-72C12BC7F95E</gtr:id><gtr:title>Prevention of PKG1a oxidation augments cardioprotection in the stressed heart.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/20a8c48cfd96c301d04a1c72dd2a9276"><gtr:id>20a8c48cfd96c301d04a1c72dd2a9276</gtr:id><gtr:otherNames>Nakamura T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/865E739E-A8C1-42E0-A496-F9BF028E8477"><gtr:id>865E739E-A8C1-42E0-A496-F9BF028E8477</gtr:id><gtr:title>S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70876a60151110f3b7628402722e2222"><gtr:id>70876a60151110f3b7628402722e2222</gtr:id><gtr:otherNames>Stathopoulou K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3EE9026C-0439-4997-ACAA-408A93518F70"><gtr:id>3EE9026C-0439-4997-ACAA-408A93518F70</gtr:id><gtr:title>Gel-based methods in redox proteomics.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4575e300de7a8474341f3fb29efe6910"><gtr:id>4575e300de7a8474341f3fb29efe6910</gtr:id><gtr:otherNames>Charles R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95CD4D76-0931-4A86-861B-64D8CCAC4689"><gtr:id>95CD4D76-0931-4A86-861B-64D8CCAC4689</gtr:id><gtr:title>Polarized cell motility induces hydrogen peroxide to inhibit cofilin via cysteine oxidation.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/378976f6c69421839c9d8ae7eb7d2af0"><gtr:id>378976f6c69421839c9d8ae7eb7d2af0</gtr:id><gtr:otherNames>Cameron JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9985AC5-1B47-4758-8366-B3F7115A9D6D"><gtr:id>E9985AC5-1B47-4758-8366-B3F7115A9D6D</gtr:id><gtr:title>Redox-guided axonal regrowth requires cyclic GMP dependent protein kinase 1: Implication for neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Redox biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9bd55c4dc71ebd938da82d6d660db4e"><gtr:id>b9bd55c4dc71ebd938da82d6d660db4e</gtr:id><gtr:otherNames>Valek L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-2317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A6B7EF0-FAA0-4101-8D83-C410E58A7BF9"><gtr:id>2A6B7EF0-FAA0-4101-8D83-C410E58A7BF9</gtr:id><gtr:title>Cysteine redox sensor in PKGIa enables oxidant-induced activation.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C744B2EC-A5FF-4749-BA39-896127B34D4F"><gtr:id>C744B2EC-A5FF-4749-BA39-896127B34D4F</gtr:id><gtr:title>Intensity matters: Ryanodine receptor regulation during exercise.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35ee8dc76583a4c956e4acac9fe24151"><gtr:id>35ee8dc76583a4c956e4acac9fe24151</gtr:id><gtr:otherNames>Kohl T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C9198582-1231-4729-AC58-5DA4242224BE"><gtr:id>C9198582-1231-4729-AC58-5DA4242224BE</gtr:id><gtr:title>Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to beta-adrenergic-like signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5DB84B81-3945-4E7E-A197-4A2114CCC0A2"><gtr:id>5DB84B81-3945-4E7E-A197-4A2114CCC0A2</gtr:id><gtr:title>Redox signaling in cardiac physiology and pathology.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23773CEE-DC2C-4ED8-9ABB-5BB9B1A5464B"><gtr:id>23773CEE-DC2C-4ED8-9ABB-5BB9B1A5464B</gtr:id><gtr:title>Approaches for monitoring PKG1a oxidative activation.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2410866A-24B0-49C0-B47A-1524C0F2B7C2"><gtr:id>2410866A-24B0-49C0-B47A-1524C0F2B7C2</gtr:id><gtr:title>Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c73a55756120cce220159e47dab14791"><gtr:id>c73a55756120cce220159e47dab14791</gtr:id><gtr:otherNames>Khavandi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/233A7812-63B2-438D-8BF8-EC54F6B0B35C"><gtr:id>233A7812-63B2-438D-8BF8-EC54F6B0B35C</gtr:id><gtr:title>Oxidant-induced activation of cGMP-dependent protein kinase Ia mediates neuropathic pain after peripheral nerve injury.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad4041c3882525ff942cb05a2345b2f7"><gtr:id>ad4041c3882525ff942cb05a2345b2f7</gtr:id><gtr:otherNames>Lorenz JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EA018D6-03BD-4C6E-9C72-EF2AA5C9AD03"><gtr:id>4EA018D6-03BD-4C6E-9C72-EF2AA5C9AD03</gtr:id><gtr:title>The PEG-switch assay: a fast semi-quantitative method to determine protein reversible cysteine oxidation.</gtr:title><gtr:parentPublicationTitle>Journal of pharmacological and toxicological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1056-8719</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D8A0DE87-4792-43E4-A553-1ACF9677ABBE"><gtr:id>D8A0DE87-4792-43E4-A553-1ACF9677ABBE</gtr:id><gtr:title>Protein kinase G oxidation is a major cause of injury during sepsis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2226d4078053c470b78cb99103ef2fa1"><gtr:id>2226d4078053c470b78cb99103ef2fa1</gtr:id><gtr:otherNames>Rudyk O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B95922D-E43D-4641-8EC4-3803EA378D01"><gtr:id>0B95922D-E43D-4641-8EC4-3803EA378D01</gtr:id><gtr:title>Protein kinase G Ia oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ac8d63c33c1e78333b00b0fead8fefd"><gtr:id>8ac8d63c33c1e78333b00b0fead8fefd</gtr:id><gtr:otherNames>Stubbert D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3728848D-E468-4C1E-8A00-230F96E13439"><gtr:id>3728848D-E468-4C1E-8A00-230F96E13439</gtr:id><gtr:title>Transcriptional Regulation of Cystathionine-?-Lyase in Endothelial Cells by NADPH Oxidase 4-Dependent Signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0963e182a9d434ecd6d81d173c2833f6"><gtr:id>0963e182a9d434ecd6d81d173c2833f6</gtr:id><gtr:otherNames>Mistry RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/645F4EE6-CA18-43A5-9A34-F4B0CD663CC9"><gtr:id>645F4EE6-CA18-43A5-9A34-F4B0CD663CC9</gtr:id><gtr:title>Persistent Activation of cGMP-Dependent Protein Kinase by a Nitrated Cyclic Nucleotide via Site Specific Protein S-Guanylation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2620fe80c290554601066c8856b8aa"><gtr:id>4a2620fe80c290554601066c8856b8aa</gtr:id><gtr:otherNames>Akashi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7D2586D-93B9-47E3-A668-158CC5F02451"><gtr:id>D7D2586D-93B9-47E3-A668-158CC5F02451</gtr:id><gtr:title>Detecting disulfide-bound complexes and the oxidative regulation of cyclic nucleotide-dependent protein kinases by H2O2.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF3B5AAB-0F85-49EE-986C-3C603F59D9D3"><gtr:id>FF3B5AAB-0F85-49EE-986C-3C603F59D9D3</gtr:id><gtr:title>cGMP-dependent activation of protein kinase G precludes disulfide activation: implications for blood pressure control.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA5E1223-B647-4701-8635-5906E66ECB60"><gtr:id>BA5E1223-B647-4701-8635-5906E66ECB60</gtr:id><gtr:title>Deficient angiogenesis in redox-dead Cys17Ser PKARIa knock-in mice.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/401B4EC0-4A32-4A1E-9101-C306B72787F2"><gtr:id>401B4EC0-4A32-4A1E-9101-C306B72787F2</gtr:id><gtr:title>Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/72b75e7496bfbdbbd17c5211cb3341d3"><gtr:id>72b75e7496bfbdbbd17c5211cb3341d3</gtr:id><gtr:otherNames>Prysyazhna O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAF9C1F5-3354-40F2-A70A-FA84F1658122"><gtr:id>CAF9C1F5-3354-40F2-A70A-FA84F1658122</gtr:id><gtr:title>Oxidant-induced Interprotein Disulfide Formation in Cardiac Protein DJ-1 Occurs via an Interaction with Peroxiredoxin 2.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10af7d54eee64eb092c93aff7d0073c1"><gtr:id>10af7d54eee64eb092c93aff7d0073c1</gtr:id><gtr:otherNames>Fernandez-Caggiano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D395C61B-E913-40D0-8F95-AC70A88F3FAF"><gtr:id>D395C61B-E913-40D0-8F95-AC70A88F3FAF</gtr:id><gtr:title>Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cbed28a17d7662fcab9fa50de717115c"><gtr:id>cbed28a17d7662fcab9fa50de717115c</gtr:id><gtr:otherNames>Charles RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84E7956E-3A85-4E8A-A813-947F4C5EF6B9"><gtr:id>84E7956E-3A85-4E8A-A813-947F4C5EF6B9</gtr:id><gtr:title>Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1a knock-in mouse.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2226d4078053c470b78cb99103ef2fa1"><gtr:id>2226d4078053c470b78cb99103ef2fa1</gtr:id><gtr:otherNames>Rudyk O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EBBDE946-5652-4C2D-B8F7-A85D49BE657B"><gtr:id>EBBDE946-5652-4C2D-B8F7-A85D49BE657B</gtr:id><gtr:title>Glyceraldehyde 3-phosphate dehydrogenase is unlikely to mediate hydrogen peroxide signaling: studies with a novel anti-dimedone sulfenic acid antibody.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/710216484300ea03973533b66c07b376"><gtr:id>710216484300ea03973533b66c07b376</gtr:id><gtr:otherNames>Maller C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/920ABC7B-DE3A-4A7B-8864-17B7F25B79CA"><gtr:id>920ABC7B-DE3A-4A7B-8864-17B7F25B79CA</gtr:id><gtr:title>The utility of N,N-biotinyl glutathione disulfide in the study of protein S-glutathiolation.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1fb21038adc4b7d9e895bf0d74069e1b"><gtr:id>1fb21038adc4b7d9e895bf0d74069e1b</gtr:id><gtr:otherNames>Brennan JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/037D6373-47BD-41EA-B1B6-C4EED82444D3"><gtr:id>037D6373-47BD-41EA-B1B6-C4EED82444D3</gtr:id><gtr:title>Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental pharmacology &amp; physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54f6b78b2da73cabaa74461d3377ee84"><gtr:id>54f6b78b2da73cabaa74461d3377ee84</gtr:id><gtr:otherNames>Bell JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1870</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/19244AE6-EF45-460B-965C-8375829BF39B"><gtr:id>19244AE6-EF45-460B-965C-8375829BF39B</gtr:id><gtr:title>Redox regulation of cGMP-dependent protein kinase Ia in the cardiovascular system.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/72b75e7496bfbdbbd17c5211cb3341d3"><gtr:id>72b75e7496bfbdbbd17c5211cb3341d3</gtr:id><gtr:otherNames>Prysyazhna O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AC86511-65DC-4D8C-8453-D70BFED20977"><gtr:id>3AC86511-65DC-4D8C-8453-D70BFED20977</gtr:id><gtr:title>Preface for redox signalling in the cardiovascular system.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/adbc495924157071709cab95e71c47f4"><gtr:id>adbc495924157071709cab95e71c47f4</gtr:id><gtr:otherNames>Eaton P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DBFCE91A-1127-4485-8965-16297B313D43"><gtr:id>DBFCE91A-1127-4485-8965-16297B313D43</gtr:id><gtr:title>Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G Ia Oxidation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/72b75e7496bfbdbbd17c5211cb3341d3"><gtr:id>72b75e7496bfbdbbd17c5211cb3341d3</gtr:id><gtr:otherNames>Prysyazhna O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59902667-F22A-4C0D-951B-D142AC54FC2C"><gtr:id>59902667-F22A-4C0D-951B-D142AC54FC2C</gtr:id><gtr:title>Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/adbc495924157071709cab95e71c47f4"><gtr:id>adbc495924157071709cab95e71c47f4</gtr:id><gtr:otherNames>Eaton P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700320</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>